Zobrazeno 1 - 10
of 32
pro vyhledávání: '"Leo Ihlberg"'
Autor:
Kentaro Hayashida, Tsuyoshi Goto, Leo Ihlberg, Morimasa Takayama, Shigeru Saito, Yoshiki Sawa
Publikováno v:
Circulation Journal. 85:991-1000
Background The REPRISE Japan study, a prospective multicenter single-arm trial, was undertaken to confirm the safety and effectiveness of transcatheter aortic valve replacement (TAVR) with the LOTUS valve in Japanese subjects with severe symptomatic
Autor:
Markku Kaarne, Antti Huuskonen, Tatu Juvonen, Jussi O. Ropponen, Peter Raivio, Johanna Valo, Leo Ihlberg
Objectives We report the mid-term outcomes of valve-sparing aortic root replacement (VSRR) in a cohort including patients with bicuspid aortic valve (BAV), connective tissue disorder (CTD), aortic dissection (AD), and congenital heart disease (CHD).
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::6ed398f892e6684bf8e3080ad25d0158
http://hdl.handle.net/10138/353239
http://hdl.handle.net/10138/353239
Autor:
Samuli J. Salmi, Markus Malmberg, Leo Ihlberg, Teemu Riekkinen, Fredrik Yannopoulos, Tuomas Kiviniemi, Fausto Biancari, Joonas Lehto, Anna Nissfolk, Maunu Nissinen, Juhani Airaksinen, Juha Hartikainen, Tuomo Nieminen
Publikováno v:
Structural Heart. 2(2):157-163
Background: The long-term incidence of stroke and the proportion of cardioembolic events after bioprosthetic surgical aortic valve replacement (SAVR) remain largely unknown.Methods: The CAREAVR stu...
Autor:
Franz-Josef Neumann, Helmut Baumgartner, José Luis Zamarano, Giuseppe Tarantini, Nicolas Dumonteil, Olaf Wendler, Leo Ihlberg, Hendrik Treede, Gerhard Schymik, Alec Vahanian
Publikováno v:
Circulation. 135:1123-1132
Background: The SOURCE 3 Registry (SAPIEN Aortic Bioprosthesis European Outcome) is a European multicenter, observational registry of the latest generation of transcatheter heart valve, the SAPIEN 3 (Edwards Lifesciences, Irvine, CA). Its purpose is
Autor:
Emilie Pelletier-Beaumont, Alfredo Giuseppe Cerillo, Martin Thoenes, Josep Rodés-Cabau, Kaj Erik Klaaborg, Simon Redwood, Caterina Gandolfo, Marc P. Pelletier, Harindra C. Wijeysundera, Rishi Puri, Pieter R. Stella, Richard Edwards, Douglas F Muir, Matthias Götberg, Asim N. Cheema, Philippe Pibarot, Francesco Meucci, Jonathan Byrne, Marko P. Virtanen, Jan Malte Sinning, Christophe Dubois, Verena Veulemans, Hélène Eltchaninoff, Ander Regueiro, Roberto Blanco-Mata, Hardy Baumbach, Ralf Müller, Leo Ihlberg
Publikováno v:
Heart, 103(2), 148. BMJ Publishing Group
While transcatheter aortic valve implantation (TAVI) is established for treating high-operative risk surgical aortic valve replacement candidates, until recently the smallest transcatheter heart valve (THV) measured 23 mm, posing greater risk for ann
Autor:
Neil J. Weissman, Leo Ihlberg, David Gerard Rizik, Robert Stoler, Tanvir Bajwa, Federico M. Asch, Dean Kereiakes, Dominic Allocco
Publikováno v:
Journal of the American College of Cardiology. 75:1479
Patient-prosthesis mismatch (PPM) is common after aortic valve replacement but its significance is controversial. Though PPM has been linked to worse outcomes post SAVR, its impact after TAVR is still unclear. We present 3-year outcomes in REPRISE II
Publikováno v:
Scandinavian Journal of Surgery. 105:35-41
Background and Aims: In this report, we present our experience with the transaortic transcatheter aortic valve implantation using the SAPIEN valve. The procedural success, 30-day outcome, and survival up to 2 years are compared with the transapical a
Autor:
Fredrik Yannopoulos, Juha Hartikainen, Tuomo Nieminen, Fausto Biancari, Otto von Hellens, Joonas Lehto, Maunu Nissinen, Teemu Riekkinen, K.E.J. Airaksinen, Leo Ihlberg, Markus Malmberg, Tuomas Kiviniemi
Publikováno v:
European heart journal. Quality of careclinical outcomes. 4(2)
Aims Post-operative atrial fibrillation (POAF) is a frequent complication after open-heart surgery, and cardioversions (CV) are commonly performed to restore sinus rhythm. However, little data exists on thrombo-embolic risk related to early post-oper
Autor:
David G. Rizik, Jeffrey Southard, Steven J. Yakubov, Michael J. Reardon, Tanvir Bajwa, Paul S. Teirstein, Leo Ihlberg, Donald E. Cutlip, Vivek Rajagopal, Dominic Allocco
Publikováno v:
Journal of the American College of Cardiology. 74:B76
REPRISE III is the first large randomized comparison of 2 TAVR platforms: the mechanically-expanded Lotus valve (Boston Scientific, Marlborough, Massachusetts) and self-expanding CoreValve (CV) (Medtronic, Dublin, Ireland). In aortic stenosis patient
Publikováno v:
The Annals of Thoracic Surgery. 95:579-585
Background Valve-sparing aortic root reconstruction (VSRR) is an accepted method to treat patients with aortic root dilation. The role of the VSRR is less well defined for patients with bicuspid aortic valve, severe aortic valve insufficiency, congen